Glaukos's Customers Performance

Name: Glaukos Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

GKOS

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


GKOS's Source of Revenues		During the corresponding time, Glaukos Corp recorded a revenue increase by 50.63 % year on year, sequentially revenue grew by 23.55 %. While revenue at the Glaukos Corp's corporate clients • List of GKOS Customers

for the same period Glaukos Corp recorded revenue increase by 50.63 % year on year, sequentially revenue grew by 23.55 %.

• List of GKOS Customers

Glaukos's Business Units


US	139.58 %	of total Revenue
Non Us	41.54 %	of total Revenue
Glaucoma	153.25 %	of total Revenue
Corneal Health	27.88 %	of total Revenue
Development and Commercialization of Ophthalmic Therapies	181.12 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Glaukos's Comment on Sales, Marketing and Customers

News about Glaukos Corp Contracts

Vision and Innovation Glaukos Corporation Expands Its Reach with New Initiatives

In a bold move underscoring its commitment to advancing ophthalmic healthcare, Glaukos Corporation has taken substantial steps to enhance both its operational capacity and its sustainable practices. Known for its groundbreaking therapies in treating glaucoma, corneal disorders, and retinal diseases, the company has recently announced a trio of initiatives that highlight its proactive approach to innovation, sustainability, and collaboration. A New Era of Innovation in Huntsville Glaukos has embarked on an ambitious expansion with the groundbreaking of a new state-of-the-art research, development, and manufacturing facility in Huntsville, Alabama. This endeavor marks a pivotal moment not only for the company ...

GKOS's Stock Performance relative to it's Customers

GKOS's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Glaukos Corp	10,391.38	500.03	-188.05	1,094
Abbvie Inc	510,171.97	64,386.00	6,316.00	57,000
Alcon inc	33,684.54	10,401.00	980.00	25,000
Johnson and Johnson	626,666.48	97,929.00	21,037.00	140,800
Sight Sciences Inc	473.38	83.35	-29.76	186
SUBTOTAL	2,341,992.74	345,598.70	56,606.49	445,972

Sources: Glaukos Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Thursday, October 15, 2026 5:23 AM
Focus of this report: Glaukos Corp’s corporate clients.
For your research, we’ve provided 9 tables on Glaukos Corp corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.